Evidence map›Paper›PMID 29599844›Full record

ArticleExperimental and therapeutic medicine2018

Effect of the polyphenol composition BP-C3 on haematological and intestinal indicators of 5-fluorouracil toxicity in mice.

Andrey V Panchenko, Elena I Fedoros, Sergey E Pigarev, Mikhail A Maydin, Ekaterina A Gubareva, Maria N Yurova, Galina S Kireeva, Galina P Lanskikh, Margarita L Tyndyk, Vladimir N Anisimov

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andrey V PanchenkoDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Elena I FedorosDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Sergey E PigarevNobel, Ltd., Saint-Petersburg 192012, Russia.
Mikhail A MaydinDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Ekaterina A GubarevaDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Maria N YurovaDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Galina S KireevaDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Galina P LanskikhDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Margarita L TyndykDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Vladimir N AnisimovDepartment of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg 197758, Russia.
Tomsk National Research Medical Center · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BP-C3 is a formulation, which comprises lignin-derived polyphenolic composition of benzenepolycarboxylic acids (BP-Cx-1) with iron complex, selenium, ascorbic acid and retinol, and possesses geroprotective activity. The present study examined the effect of BP-C3 (80 mg/kg, administered 18 times in total by gavage) on the development of haematological and intestinal manifestations of toxicity following 5-fluorouracil (5-FU; 150 mg/kg, administered once via intravenous injection) administration in outbred male Swiss-H Rappolovo (SHR) mice. The use of BP-C3 on therapeutic and preventative/therapeutic schedules demonstrated that it was protective against the toxic effect of 5-FU exerted on the lymphopoietic organs. Administering ВР-С3 24 h after 5-FU (therapeutic schedule) had an effect on the recovery of leukopoiesis and prevented anaemia in the mice. In the mice that received 5-FU and 5-FU with BP-C3 prior to and following administration of the chemotherapeutic agent (preventative/therapeutic schedule), mild anaemia developed by day 7. Administration of BP-C3 without 5-FU did not affect blood cell differentiation in the mice. Thus, BP-C3, depending on the administration schedule, had different effects on the haematological parameters of haematopoietic organs and peripheral blood in mice exposed to 5-FU. BP-C3 promoted intestinal crypt survival when administered on the preventative/therapeutic and therapeutic schedules, suggesting that the formulation protects the epithelium of the small intestine against damage by 5-FU.

Indexed as

5-fluorouracilbenzenepolycarboxylic acidsblood countchemotherapyintestinal crypt survivalpolyphenol composition BP-C3toxicity

Identifiers

PMID29599844
PMCPMC5867459
OpenAlexW2791543036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.